Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Medullary × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8 Breast Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 4 Barrett Esophagus 4 Lymphoma, Large B-Cell, Diffuse 3 Inflammation 3 Head and Neck Neoplasms 3 Zollinger-Ellison Syndrome 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumours 1 Solid Tumor 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Precancerous Gastric Lesions 1 Pharmacokinetics of MDV3100 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

vandetanib 14 cabozantinib 8 selpercatinib 6 Everolimus 5 Sorafenib 4 Magnetic Resonance Spectroscopy 3 Capecitabine 3 sargramostim 2 pralsetinib 2 lutetium Lu 177 dotatate 2 lenvatinib 2 Trastuzumab 2 Temozolomide 2 Sunitinib 2 Octreotide 2 Gefitinib 2 yeast-CEA vaccine 1 veliparib 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sacubitril and valsartan sodium hydrate drug combination 1 ponatinib 1 pentetreotide 1 pembrolizumab 1 pazopanib 1 pasireotide 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01539655 2017-05-02

Vandetanib

Sanofi

Phase 1 Completed

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡